USFDA inspection at Kolhapur API facility closed with 5 procedural observations

Regulatory & Legal View source PDF Explain this filing

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+8.6%Reaction day

₹377.95

prior close

₹389.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%+4.9% vs market

Pharmaceuticals peers, median of 157sector+2.6%+6.1% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 6.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.9

10m

-1.1

15m

+2.1

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+8.6+3.7+4.9+2.6+6.1

Next day

+10.1+5.1+5.0+2.5+7.6

+12.0+4.0+8.0+1.6+10.4

+5.6+3.2+2.4+1.1+4.4

+3.7+5.9-2.2+2.9+0.8

+2.5+6.9-4.5+3.6-1.1

+1.7+5.9-4.1+2.6-0.8

15d

-5.3+2.1-7.3-0.6-4.7

-16.4-3.5-12.9-2.6-13.8

-20.6-4.2-16.4-4.7-15.9

+0.7+10.9-10.2+4.2-3.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

USFDA inspected Unichem Labs' Kolhapur API facility from 27 Jan to 2 Feb 2026. The inspection closed with five observations, all described as procedural in nature, with none related to data integrity. The company will submit its response to USFDA within the stipulated 15 days.

Likely market impact

Reassuring outcome since observations are procedural only and no data integrity issues flagged; Kolhapur facility supplies the US generics market.